Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
JAMA|September 3, 2020
Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19: A Randomized Clinical TrialPierre-François Dequin, Nicholas Heming, Ferhat Meziani, et al.
Pediatric Blood & Cancer|June 8, 2018
Outcome of children and adolescents with Down syndrome treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00-001 and 05-001Uma H Athale, Maneka Puligandla, Kristen E Stevenson, et al.
Blood Advances|January 26, 2021
Genetic ancestry and skeletal toxicities among childhood acute lymphoblastic leukemia patients in the DFCI 05-001 cohortSong Yao, Qianqian Zhu, Peter D Cole, et al.
Pediatric Blood & Cancer|March 22, 2022
Predictors of thrombosis in children receiving therapy for acute lymphoblastic leukemia: Results from Dana-Farber Cancer Institute ALL Consortium trial 05-001Uma H Athale, Yael Flamand, Traci Blonquist, et al.
Pediatric Blood & Cancer|November 2, 2017
An investigation of toxicities and survival in Hispanic children and adolescents with ALL: Results from the Dana-Farber Cancer Institute ALL Consortium protocol 05-001Justine M Kahn, Peter D Cole, Traci M Blonquist, et al.
JAMA Network Open|April 27, 2019
Molecular Profiling of Hard-to-Treat Childhood and Adolescent CancersFida Khater, Stephanie Vairy, Sylvie Langlois, et al.
Emerging Infectious Diseases|December 27, 2022
Widespread Exposure to Mosquitoborne California Serogroup Viruses in Caribou, Arctic Fox, Red Fox, and Polar Bears, CanadaKayla J Buhler, Antonia Dibernardo, Nicholas W Pilfold, et al.
Blood Advances|June 27, 2018
Refining risk classification in childhood B acute lymphoblastic leukemia: results of DFCI ALL Consortium Protocol 05-001Lynda M Vrooman, Traci M Blonquist, Marian H Harris, et al.
Trials|August 25, 2020
Corticosteroid therapy for critically ill patients with COVID-19: A structured summary of a study protocol for a prospective meta-analysis of randomized trialsJonathan A C Sterne, Janet Diaz, Jesús Villar, et al.
Blood Advances|March 7, 2018
Prognostic impact of kinase-activating fusions and IKZF1 deletions in pediatric high-risk B-lineage acute lymphoblastic leukemiaThai Hoa Tran, Marian H Harris, Jonathan V Nguyen, et al.
Pageof 8